Clinicopathological Features of Oral Leukoplakia Among Snuff Users and Non-Users: An Analytical Study: Clinicopathological Features of Oral Leukoplakia

Tehmina  Naushin; Abbas Saleem  Khan; Sadaf  Alam; Nasiha  Motahir; Fatima Iqbal; Hoor Maryam  Younas; Sidra  Mahmood; Uzma  Mahmood

doi:10.54393/pjhs.v4i06.845

Authors

Tehmina Naushin Department of Oral Pathology, Peshawar Dental College, Peshawar, Pakistan
Abbas Saleem Khan Department of Oral Pathology, Peshawar Dental College, Peshawar, Pakistan
Sadaf Alam Department of Histopathology, Peshawar Medical College, Peshawar, Pakistan
Nasiha Motahir Department of Oral Pathology, Peshawar Dental College, Peshawar, Pakistan
Fatima Iqbal Department of Oral Pathology, Peshawar Dental College, Peshawar, Pakistan
Hoor Maryam Younas Department of Oral Pathology, Peshawar Dental College, Peshawar, Pakistan
Sidra Mahmood Kabir Medical College, Gandhara University, Peshawar, Pakistan
Uzma Mahmood Khyber Medical College, Peshawar, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v4i06.845

Keywords:

Oral Leukoplakia, Histopathology, Dysplasia, Snuff

Abstract

Oral leukoplakia refers to a white lesion of questionable risk excluding other lesions carrying a risk of conversion into malignancy. Tobacco is regarded as the most common risk factor and may affect the clinicopathological aspect of the said lesion. Objectives: To check the clinicopathological features of oral leukoplakia among snuff users and non-users. Methods: The present analytical study was done on 60 oral leukoplakia cases and was further subdivided into 30 cases of snuff users and 30 non users. Clinicopathological features were assessed in all the cases. Data analysis were done by using SPSS-20. Results: The observed male cases were 43 (71.7 %) and female cases were 17 (28.3%). The ratio was found to be 2.5:1. All the 30 snuff users were males. Among non-users 13/30 (43.3%) were males and 17/30 (56.7%) were females. The relationship was found to be statistically significant with a p-value of <0.01. The mean age among cases who used snuff was 56.97 (SD ± 14.71) while the mean age among non-users was found to be 47.43 (SD ± 13.44). In snuff user’s buccal mucosa was affected in 12/30 (40%) cases whereas in non-user buccal mucosa was also the most common site 18/30 (60%) cases showing a non-significant relationship p-value 0.59. Conclusions: Oral leukoplakia was more prevalent among males with a mean age range of more than fifty years and buccal mucosa and buccal sulcus being the most common sites. Dysplastic epithelium was more common among those cases that used snuff and this showed that chances of malignant transformation are more in such cases.

References

Naushin T, Khan MM, Ahmed S, Iqbal F, Bashir N, Khan AS. Determination of Ki-67 expression in oral leukoplakia in snuff users and non-users in Khyber Pakhtunkhwa province of Pakistan. The Professional Medical Journal. 2020 Apr; 27(04): 682-7. doi: 10.29309/TPMJ/2020.27.04.3124. DOI: https://doi.org/10.29309/TPMJ/2020.27.04.3124

Shetty P, Hegde S, Vinod KS, Kalra S, Goyal P, Patel M. Oral Leukoplakia: Clinicopathological Correlation and Its Relevance to Regional Tobacco-related Habit Index. The Journal of Contemporary Dental Practice. 2016 Jul; 17(7): 601-8. doi: 10.5005/jp-journals-10024-1897. DOI: https://doi.org/10.5005/jp-journals-10024-1897

Jagtap SV, Warhate P, Saini N, Jagtap SS, Chougule PG. Oral premalignant lesions: a clinicopathological study. International Surgery Journal. 2017 Sep; 4(10): 3477-81. doi: 10.18203/2349-2902.isj20174520. DOI: https://doi.org/10.18203/2349-2902.isj20174520

Yang SW, Lee YS, Wu PW, Chang LC, Hwang CC. A retrospective cohort study of oral leukoplakia in female patients—analysis of risk factors related to treatment outcomes. International Journal of Environmental Research and Public Health. 2021 Aug; 18(16): 8319. doi: 10.3390/ijerph18168319. DOI: https://doi.org/10.3390/ijerph18168319

Venkat A, Aravindhan R, Magesh KT, Sivachandran A. Analysis of Oral Leukoplakia and Tobacco-Related Habits in Population of Chengalpattu District-An Institution-Based Retrospective Study. Cureus. 2022 Jun; 14(6): 1-6. doi: 10.7759/cureus.25936. DOI: https://doi.org/10.7759/cureus.25936

van der Waal I. Oral leukoplakia: present views on diagnosis, management, communication with patients, and research. Current Oral Health Reports. 2019 Mar; 6: 9-13. doi: 10.1007/s40496-019-0204-8. DOI: https://doi.org/10.1007/s40496-019-0204-8

Naushin T, Khan AS, Ishfaq M, Bashir N, Iqbal F, ul Hassan M. Histopathological assessment of oral leukoplakia among snuff users and non-users. Journal of Medical Sciences. 2023 Mar; 31(01): 72-5. doi: 10.52764/jms.23.31.1.14. DOI: https://doi.org/10.52764/jms.23.31.1.14

Grandis E-NACJ and WHO JTTSP. WHO classification of head and neck tumours. IARC. Lyon. 2017. [Last Cited: 3rd Jul 2023]. Available at: http://125.212.201.8:6008/handle/DHKTYTHD_123/13486.

Villa A and Woo SB. Leukoplakia—a diagnostic and management algorithm. Journal of Oral and Maxillofacial Surgery. 2017 Apr; 75(4): 723-34. doi: 10.1016/j.joms.2016.10.012. DOI: https://doi.org/10.1016/j.joms.2016.10.012

Rao JP. Potentially malignant lesion-Oral leukoplakia. Global Advances Research Journal of Medicine and Medical Sciences. 2012 Dec; 1: 286-91.

Parlatescu I, Gheorghe C, Coculescu E, Tovaru S. Oral leukoplakia–An update. Maedica. 2014 Mar; 9(1): 88.

Hosagadde S, Dabholkar J, Virmani N. A clinicopathological study of oral potentially malignant disorders. Journal of Head & Neck Physicians and Surgeons. 2016 Jan; 4(1): 29. doi: 10.4103/2347-8128.182853. DOI: https://doi.org/10.4103/2347-8128.182853

Parakh MK, Ulaganambi S, Ashifa N, Premkumar R, Jain AL. Oral potentially malignant disorders: clinical diagnosis and current screening aids: a narrative review. European Journal of Cancer Prevention. 2020 Jan; 29(1): 65-72. doi: 10.1097/CEJ.0000000000000510. DOI: https://doi.org/10.1097/CEJ.0000000000000510

Khan AS, Ahmad S, Iqbal F, Saboor A, Nisar M, Naushin T, et al. A immunohistochemical expression of P53 in oral squamous cell carcinoma, oral epithelial precursor lesions, and normal oral mucosa. Journal of Medical Sciences. 2021; 29(04): 255-60. doi: 10.52764/jms.21.29.4.9. DOI: https://doi.org/10.52764/jms.21.29.4.9

Chen Q, Dan H, Pan W, Jiang L, Zhou Y, Luo X, et al. Management of oral leukoplakia: a position paper of the Society of Oral Medicine, Chinese Stomatological Association. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2021 Jul; 132(1): 32-43. doi: 10.1016/j.oooo.2021.03.009. DOI: https://doi.org/10.1016/j.oooo.2021.03.009

Saldivia-Siracusa C and González-Arriagada WA. Difficulties in the prognostic study of oral leukoplakia: standardisation proposal of follow-up parameters. Frontiers in Oral Health. 2021 Feb; 2: 614045. doi: 10.3389/froh.2021.614045. DOI: https://doi.org/10.3389/froh.2021.614045

Mao T, Xiong H, Hu X, Hu Y, Wang C, Yang L, et al. DEC1: a potential biomarker of malignant transformation in oral leukoplakia. Brazilian Oral Research. 2020 Jun; 34: 1-9. doi: 10.1590/1807-3107bor-2020.vol34.0052. DOI: https://doi.org/10.1590/1807-3107bor-2020.vol34.0052

Mello FW, Miguel AF, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra EN, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta‐analysis. Journal of Oral Pathology & Medicine. 2018 Aug; 47(7): 633-40. doi: 10.1111/jop.12726. DOI: https://doi.org/10.1111/jop.12726

Mondal K, Mandal R, Sarkar BC, Das V. An inter-correlative study on clinico-pathological profile and different predisposing factors of oral leukoplakia among the ethnics of Darjeeling, India. Journal of Orofacial Sciences. 2017 Jan; 9(1): 34-42. doi: 10.4103/0975-8844.207942. DOI: https://doi.org/10.4103/0975-8844.207942

Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2018 Jun; 125(6): 582-90. doi: 10.1016/j.oooo.2018.03.011. DOI: https://doi.org/10.1016/j.oooo.2018.03.011

Giovannacci I, Magnoni C, Pedrazzi G, Vescovi P, Meleti M. Clinicopathological features associated with fluorescence alteration: analysis of 108 oral malignant and potentially malignant lesions. Photobiomodulation, Photomedicine, and Laser Surgery. 2021 Jan; 39(1): 53-61. doi: 10.1089/photob.2020.4838. DOI: https://doi.org/10.1089/photob.2020.4838

Diajil A, Robinson CM, Sloan P, Thomson PJ. Clinical outcome following oral potentially malignant disorder treatment: a 100 patient cohort study. International Journal of Dentistry. 2013 Jan; 2013: 1-8. doi: 10.1155/2013/809248. DOI: https://doi.org/10.1155/2013/809248

Kumar P, Kane S, Rathod GP. Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India. Brazilian Oral Research. 2012 May; 26(3): 228-34. doi: 10.1590/S1806-83242012000300008. DOI: https://doi.org/10.1590/S1806-83242012000300008

Patel U, Shah R, Patel A, Shah S, Patel D, Patel A. Effect of tobacco in human oral leukoplakia: a cytomorphometric analysis. Medicine and Pharmacy Reports. 2020 Jul; 93(3): 273. doi: 10.15386/mpr-1439 DOI: https://doi.org/10.15386/mpr-1439